Media centre

3i invests $160 million in Q Holding

3i Group plc (“3i”), the international investment manager, has agreed to invest approx. $160 million (c. £100 million) in Q Holding (“the Company”), the Ohio-headquartered leading global manufacturer of highly engineered, precision moulded rubber and silicone components.

Q Holding, through its subsidiaries QSR and Qure Medical, is a manufacturer of elastomeric products, primarily serving the automotive, medical and pharmaceutical end markets. Its value proposition lies in its material science and engineering capabilities which enable Q Holding to produce components that meet the tight quality and performance specifications required for the demanding end markets it serves. The Company’s main product categories include electrical management solutions such as connector seals and ignition insulators, as well as a broader range of components for disposable medical and pharmaceutical products such as catheters and syringe plungers.  

The Company has an international footprint with over 1,100 employees across six manufacturing facilities in North America and China, selling products in over 50 countries. Q Holding and 3i plan to continue the Company’s growth by accelerating its expansion into Europe, and broadening its product and end market offering.  

The 3i deal team comprised individuals from the US, German, UK and French offices. 3i’s strong track record of helping its portfolio companies internationalise and enter new markets was a key attraction to the Company’s management team when picking a partner for the business. Recent examples within the industrial sector where 3i has successfully helped management deliver on their international expansion strategy include MoldMasters, Hilite, Hyva and NORMA. In addition to organic growth, Q Holding will also continue to seek to expand its offering through selective acquisitions in Europe and North America within the highly fragmented silicone moulding sector.  

Richard Relyea, Partner, 3i North America, said:  
“We’re pleased to announce our investment in Q Holding. It is an excellent business and a global leader in the majority of its product categories. We look forward to working with the management team to build upon this strong platform for growth, in particular, leveraging our local presence and network to help accelerate the Company’s continued international expansion.”   

Randy Ross, Chief Executive of Q Holding, commented:  
“The management team at Q Holding is very excited to have a partner that shares the company’s vision, and has the network to help us be a global partner to our key customers.  Our shared vision of “customer first” philosophies and 3i’s unique position to help support Q Holding’s end market strategies makes 3i an ideal partner for the business.”   

-Ends-

Download this press release as PDF 

 

 

Regulatory information

This transaction involved a recommendation of 3i Corporation, a US wholly owned subsidiary of 3i Group. 


  
For further information, contact:  

3i Group plc
Kathryn van der Kroft
Tel: +44 20 7975 3021  
Email: kathryn.vanderkroft@3i.com

Latika Shah  
Tel: +44 20 7975 3157
Email: latika.shah@3i.com   

Notes to editors:  

About 3i Group 
3i is a leading international investment manager focused on mid-market private equity, infrastructure and debt management across Europe, Asia and North America. For further information, please visit: www.3i.com.  

About Q Holding  
Q Holding is committed to providing world class precision moulded elastomeric components. Through QSR, we provide electrical management solutions to our customers in the automotive, industrial and aerospace industry. Qure Medical supplies engineered elastomeric products to the medical and pharmaceutical industry. For further information, please visit: www.qsr-inc.com and www.qure-medical.com.

Back to top